4/26/24 12:50 | 4/25/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 25 | 11.96 | 0 | 2 | 1 | 171 | D | | | | | | | | | | | | | | |
4/26/24 12:38 | 4/25/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | M.d | 10 | 11.96 | 0 | 1 | 2 | 47 | D | | | | | | | | | | | | | | |
4/26/24 09:48 | 4/25/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | M.d | 7 | 11.96 | 0 | 1 | 6 | 10 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
11/3/23 13:59 | 11/3/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
10/26/23 08:01 | 10/25/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 152 | 15.17 | 0 | 10 | 38 | 36 | D | | | | | | | | | | | | | | |
10/17/23 10:06 | 10/13/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -5 | 15.10 | 0 | 0 | -1 | 27 | D | | | | | | | | | | | | | | |
10/12/23 16:01 | 10/12/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
10/12/23 11:54 | 10/11/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | S | -40 | 15.61 | 0 | -3 | -10 | 25 | D | | | | | | | | | | | | | | |
10/12/23 11:25 | 10/11/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -30 | 15.69 | 0 | -2 | -7 | 26 | D | | | | | | | | | | | | | | |
10/11/23 16:21 | 10/11/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 150 | 15.03 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
8/22/23 10:57 | 8/18/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 23 | 15.62 | 0 | 2 | 7 | 25 | D | | | | | | | | | | | | | | |
8/22/23 10:57 | 8/18/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | S.d | -34 | 22.59 | 0 | -2 | -6 | 25 | D | | | | | | | | | | | | | | |
1/30/23 17:04 | 1/26/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 38 | 17.11 | 0 | 2 | 10 | 25 | D | | | | | | | | | | | | | | |
1/18/23 17:04 | 1/13/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 45 | 17.91 | 0 | 3 | 27 | 12 | D | | | | | | | | | | | | | | |
10/11/22 19:09 | 10/11/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 58 | 11.63 | 0 | 5 | 18 | 33 | D | | | | | | | | | | | | | | |
10/4/22 18:43 | 10/3/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 28 | 13.89 | 0 | 2 | 9 | 23 | D | | | | | | | | | | | | | | |
9/28/22 17:29 | 9/28/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 100 | 14.31 | 0 | 7 | 254 | 10 | D | | | | | | | | | | | | | | |
9/28/22 17:27 | 9/28/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 316 | 14.37 | 0 | 22 | 38 | 80 | D | | | | | | | | | | | | | | |
8/17/22 20:15 | 8/16/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Vetter Darci L | MI | D | | P | 24 | 21.83 | 0 | 1 | 387 | 1 | D | | | | | | | | | | | | | | |
8/10/22 14:27 | 7/27/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 148 | 22.70 | 0 | 7 | 123 | 12 | D | | | | | | | | | | | | | | |
8/4/22 19:03 | 8/2/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | P | 34 | 22.50 | 0 | 2 | 16 | 11 | D | | | | | | | | | | | | | | |
8/2/22 14:28 | 7/29/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 404 | 23.07 | 0 | 18 | 43 | 58 | D | | | | | | | | | | | | | | |
7/28/22 13:04 | 7/27/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 22.98 | 0 | 2 | 17 | 14 | D | | | | | | | | | | | | | | |
1/28/22 18:43 | 1/25/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | Chief Co | P | 50 | 35.78 | 0 | 1 | 146 | 2 | D | | | | | | | | | | | | | | |
1/18/22 18:11 | 1/12/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 47 | 15.62 | 0 | 3 | 16 | 21 | D | | | | | | | | | | | | | | |
1/18/22 18:11 | 1/12/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | S.d | -120 | 40.00 | 0 | -3 | -12 | 21 | D | | | | | | | | | | | | | | |
12/28/21 17:41 | 12/23/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | M.d | 20 | 31.35 | 0 | 1 | 3 | 21 | D | | | | | | | | | | | | | | |
12/28/21 17:41 | 12/23/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -29 | 44.91 | 0 | -1 | -3 | 21 | D | | | | | | | | | | | | | | |
9/30/21 18:28 | 9/29/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | M.dm | 378 | 20.23 | 0 | 19 | 201 | 28 | D | | | | | | | | | | | | | | |
9/30/21 18:28 | 9/29/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | S.dm | -817 | 43.80 | 0 | -19 | -40 | 28 | D | | | | | | | | | | | | | | |
9/30/21 18:10 | 9/30/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | M.d | 324 | 20.23 | 0 | 16 | 400 | 20 | D | | | | | | | | | | | | | | |
9/30/21 18:10 | 9/30/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -699 | 43.72 | 0 | -16 | -44 | 20 | D | | | | | | | | | | | | | | |
9/24/21 17:49 | 9/23/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 43 | 42.92 | 0 | 1 | 9 | 12 | D | | | | | | | | | | | | | | |